LONGi's Hi-MO 9 Modules Achieve Prestigious 'Pacesetter' Certification
March 24, 2025 - 12:32
LONGi has announced that its second-generation HPBC technology, the Hi-MO 9 module, has been awarded the prestigious 'Pacesetter' advanced technology certification by the China General Certification agency (CGC). This recognition underscores the innovative advancements in solar technology that LONGi continues to pioneer.
The Hi-MO 9 modules, featuring the latest in high-performance bifacial cell technology, are designed to enhance energy efficiency and output. This certification not only highlights the product's superior performance but also reinforces LONGi's commitment to sustainability and renewable energy solutions.
With the growing global emphasis on clean energy, the Hi-MO 9 modules are expected to play a significant role in promoting solar energy adoption. The 'Pacesetter' certification positions LONGi as a leader in the photovoltaic industry, setting a benchmark for quality and innovation. As the demand for efficient solar solutions increases, LONGi's latest offering is poised to meet the needs of both residential and commercial sectors.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...